The National Diabetes Center - a diabetes think-tank and patient advocacy group for physicians

<body> <p><br> </p> <table border="0"> <tr> <td align="center" valign="top" target="_top"><font color="#000000" size="2"><strong><br> <br> </strong></font></td> <th rowspan="2" colspan="2" bgcolor="#7DB1F0" bordercolor="#000000" bordercolordark="#000000" bordercolorlight="#000000" nowrap><p align="center"><a href="http://www.niddk.nih.gov/new/releases/9_1_99.htm" target="nihwin"><font color="#000000" size="2"><strong>The National Heart, Lung, and Blood Institute (NHLBI) and </strong></font></a><font color="#000000" size="2"><strong><br> </strong></font><a href="http://www.niddk.nih.gov/new/releases/9_1_99.htm" target="nihwin"><font color="#000000" size="2"><strong>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) </strong></font></a><a href="http://www.niddk.nih.gov/new/releases/9_1_99.htm" target="nihwin"><font color="#000000" size="2"><strong>of the National Institutes of Health (NIH) </strong></font></a><font color="#000000" size="2"><strong><br> </strong></font><a href="http://www.niddk.nih.gov/new/releases/9_1_99.htm" target="nihwin"><font color="#000000" size="2"><strong>have collaborated with three leading private health organizations </strong></font></a><font color="#000000" size="2"><strong><br> </strong></font><a href="http://www.niddk.nih.gov/new/releases/9_1_99.htm" target="nihwin"><font color="#000000" size="2"><strong>on a major public health statement </strong></font></a><font color="#000000" size="2"><strong><br> </strong></font><a href="http://www.niddk.nih.gov/new/releases/9_1_99.htm" target="main2"><font color="#000000" size="2"><strong>to alert physicians, patients, and the general public to the </strong></font></a></p> <table border="0"> <tr> <td bgcolor="#D8D8CD"><a href="http://www.niddk.nih.gov/new/releases/9_1_99.htm" target="nihwin"><font color="#6A6733" size="4"><strong>"</strong></font></a><a href="http://www.niddk.nih.gov/new/releases/9_1_99.htm" target="nihwin"><font color="#6A6733" size="4"><strong>INCREASING SIGNIFICANCE OF DIABETES MELLITUS</strong></font></a><font color="#6A6733" size="4"><strong><br> </strong></font><a href="http://www.niddk.nih.gov/new/releases/9_1_99.htm" target="nihwin"><font color="#6A6733" size="4"><strong>AS A MAJOR RISK FACTOR FOR CARDIOVASCULAR DISEASE</strong><em><strong>"</strong></em></font></a></td> </tr> </table> <p align="center"><font color="#000000" size="2"><strong><br> </strong></font><font color="#000000"><strong>L</strong></font><a href="http://jama.ama-assn.org/issues/v282n21/full/jrv90051.html" target="atherowin"><font color="#000000"><strong>ipid-lowering therapy generally should be more aggressively applied </strong></font></a><font color="#000000"><strong><br> </strong></font><a href="http://jama.ama-assn.org/issues/v282n21/full/jrv90051.html" target="atherowin"><font color="#000000"><strong>to patients with diabetes and/or at the time of coronary heart disease (CHD) diagnosis</strong></font></a><font color="#000000" size="3"><strong><br> (</strong></font><font color="#000000" size="2"><strong>v.o. </strong></font><a href="gut.htm" target="nihwin"><font color="#000000" size="2"><strong>G.U.T. of Diabetic Complications</strong></font></a><font color="#000000" size="3"><strong>)</strong></font><font color="#FFFFFF" size="4"><strong><br> </strong></font></p> </th> </tr> </table> <p>This page uses frames, but your browser doesn't support them. Click on <a href="http://www.diabetes-mellitus.org/index3.htm">The National Diabetes Center - a diabetes think-tank and patient advocacy group for physicians</a></p> </body>